Navigation Links
Bacterin International Holdings, Inc. Receives Approval for Listing on NYSE Amex
Date:3/4/2011

BELGRADE, Mont., March 4, 2011 /PRNewswire/ -- Bacterin International Holdings, Inc. (OTC Bulletin Board: BIHI) ("Bacterin"), a creator and developer of revolutionary bone graft material and anti-infective coatings for medical applications, today announced that its common stock has been approved for listing on the NYSE Amex and has chosen Knight Capital Group as its designated market maker.  Shares of Bacterin's common stock will commence trading on the NYSE Amex on Monday, March 7, 2011 under the new ticker symbol "BONE".

"This is truly an eventful period in our company's history as we proudly commence the trading of our stock on the NYSE Amex.  We believe our shares will experience higher liquidity as a NYSE Amex listed company, which will raise our profile in the investment community," said Guy Cook, founder and CEO of Bacterin.  "Over 12 years ago, we launched Bacterin with the goal to create interventional therapeutic products that encourage surgeons to treat patients earlier in the disease cascade.  As a result, our core technology in both biological scaffolds for tissue regeneration and antimicrobial coatings offers patients faster, safer and more effective healing results at a greatly reduced overall cost to the medical provider.  Today we have an increasing commercialized product portfolio uniquely addressing current trends and needs within the healthcare industry."

"We welcome Bacterin International Holdings, Inc. to the NYSE Euronext family of listed companies and to NYSE Amex," said Scott Cutler, EVP and Co-Head of U.S. Listings and Cash Execution, NYSE Euronext.  "Bacterin and its shareholders will benefit from superior market quality and technology, a broad array of issuer and investor services, and a global brand association.  We look forward to building a strong and lasting partnership with the Company an
'/>"/>

SOURCE Bacterin International Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Bacterin International Announces Major Orthopedic Hospital Group to Begin Use of OsteoSponge®SC
2. Bacterin International to Announce Launch of OsteoSponge®SC at American Academy of Orthopedic Surgeons 2011 Annual Meeting February 15-19
3. Bacterin International Holdings to Present at the OneMedForum San Francisco 2011
4. Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results
5. Bacterin International Holdings, Inc. Schedules Conference Call to Present Third Quarter 2010 Financial Results
6. Bacterin International to Present at Singular Research 5th Annual Best of the Uncovereds Conference
7. Bacterin International Holdings, Inc. to Present at the 6th Annual Fall Growth Stock Conference Hosted by Security Research Associates, Inc.
8. Bacterin International Holdings, Inc. Completes Merger and $7.5 Million Raise
9. Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlanes Network of Over 6,000 Medical Facilities
10. Bacterin International Introduces OsteoSelect(R) DBM Putty
11. Bacterin International Completes $3 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... -- The new 13-valent pneumococcal conjugate vaccine (PCV13) appears ... prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), ... Vaccine. The U.S. Food and Drug Administration ... series of trials. These trials found that PCV13, which ... the previously used PCV7, did not increase the risk ...
(Date:5/22/2013)... -- Pomerantz Grossman Hufford Dahlstrom ... investors of Intuitive Surgical, Inc. ("Intuitive Surgical" or the ... purchased Intuitive Surgical common stock between October 19, 2011 ... are advised to contact Robert S. Willoughby ... 237. The investigation concerns whether Intuitive Surgical ...
(Date:5/22/2013)... Hemoglobin A1C levels increased over a ... diabetes, while modest improvements in A1C control has ... lead to substantial healthcare cost savings, according to ... Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual International ... Valeritas, makers of the V-Go ® insulin ...
Breaking Medicine Technology:Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6
... 2010 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: ... adopted at its annual general meeting of shareholders ... (Logo: http://photos.prnewswire.com/prnh/20040705/CNM002LOGO) (Logo: ... PharmaTech shareholders approved the re-election of incumbent Class ...
... 2010 Abaxis, Inc. (Nasdaq: ABAX ), ... today announced the release of a new Piccolo® reagent ... disc will be used by healthcare professionals in conjunction ... of this new panel configuration, U.S. healthcare professionals can ...
Cached Medicine Technology:WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting 2Abaxis Increases Reagent Disc Offering for Physician Office Market With Release of BioChemistry Panel Plus 2Abaxis Increases Reagent Disc Offering for Physician Office Market With Release of BioChemistry Panel Plus 3
(Date:5/22/2013)... 22, 2013 Zensah® Compression Apparel released ... article titled "Breast pain while running affects ... could help." According to the article, a British ... substantial amount suffer from breast pain while running but ... the issue. , Zensah emphasizes the importance for ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 People in the ... is leading to water shortages. In much of the world, ... to water advocate, Sharon Kleyne. She warns against taking water ... water that is available so easily in the United States. ... Power of Water radio show, heard live or by podcast ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Diversity Focus ... Handicap This! The performance promotes awareness that physical ... The Handicap This! performance will be held Friday, June ... School auditorium. Tickets for Handicap This! can be ... helps audiences measure the level to which their mind ...
(Date:5/22/2013)... University of Michigan study challenges previous research that ... , The study, a collaboration between researchers at ... looks deeper into the controversial argument over whether ... for pitchers of the same race. It found ... Jason Winfree, associate professor of sport management at ...
(Date:5/22/2013)... may be reaping enormous income for patients whose ... contracted in their intensive care units. , In ... American Journal of Medical Quality , the ... an avoidable central line-associated bloodstream infection (CLABSI) costs ... a similar infection-free patient. Moreover, hospitals earn nearly ...
Breaking Medicine News(10 mins):Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:Water Advocate Sharon Kleyne Announces Water Conservation Appreciation 2Health News:Handicap This! Comes to Marion, Iowa 2Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4
... at the University of Adelaide will focus on treatment ... and genetic variations between people. The Centre for ... researchers with strengths in blood cancers and solid tumours, ... Professor David Callen, the team will use tumour profiling ...
... -- The risk of burns increases over the holiday ... flammable decorations and using fireplaces and candles. "We ... and Christmas. Your holiday, which should be full of ... Guy, director of Vanderbilt Regional Burn Center in Nashville, ...
... research shows 63% of women age 50 and older ... 12-year study period. Predictors for persistent pain included higher ... osteoarthritis (OA). Details of this longitudinal study are available ... by Wiley-Blackwell on behalf of the American College of ...
... an important regulatory enzyme may slow the loss of ... neurodegenerative disorders. In a report receiving advance online ... Hospital (MGH)-based research team reports that increased expression of ... in the brain of a mouse model of HD ...
... , SATURDAY, Dec. 17 (HealthDay News) -- The ... at this time of year it is especially important to ... "Holiday get-togethers tend to lead people to consume sugary treats ... spokesperson for the Academy of General Dentistry, said in an ...
... for the treatment of breast cancer has been ... the U.S. as an alternative to standard whole-breast ... 16th in the Journal of the ... APBI recurrence (external beam radiation, intraoperative radiotherapy, brachytherapy ...
Cached Medicine News:Health News:New personalized treatment options for cancer 2Health News:Christmas Trees and Trappings Can Fan Fire Risk 2Health News:Knee pain common complaint in middle-aged and mature women 2Health News:Regulatory enzyme overexpression may protect against neurodegeneration in Huntington's disease 2Health News:Dentist Gives Advice to Keep Holiday Smiles Bright 2Health News:Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy 2Health News:Advantages and motivations uncertain behind use of brachytherapy for breast cancer radiotherapy 3
The Riboprinter microbial characterization system provides the speed, accuracy and resolution needed to identify microorganisms and characterize them efficiently and consistently. These determination...
A versatile plate washer and/or dispenser that aspirates from the top down without immersing the aspirating tubes in the well, ensuring overflow protection. 5 programmable protocols....
The Finstrip 4 is an effective and reliable microplate washer offering high performance, simplicity and ease of use....
... 1575 immunowash microplate washer ... needle position to perform ... maximize wash efficiency. This ... choice of wash that ...
Medicine Products: